Powering Neurology Drug Development Trials to Reduce False Negative Results.
Saved in:
| Title: | Powering Neurology Drug Development Trials to Reduce False Negative Results. |
|---|---|
| Authors: | Mori H; EPoC Science Ltd, Oxford, UK., Wiklund SJ; Captario AB, Gothenburg, Sweden., Ramanarayanan V; Modality.AI Inc, San Francisco, California, USA.; University of California San Francisco, San Francisco, California, USA., Nahab FB; Neuron23, South San Francisco, California, USA.; University of California San Diego, La Jolla, California, USA. |
| Source: | Clinical and translational science [Clin Transl Sci] 2026 Sep; Vol. 19 (9), pp. e70722. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1752-8062 |
|---|---|
| DOI: | 10.1111/cts.70722 |
